2030년까지의 남미 및 중미 오피오이드 시장 전망 - 지역 분석 - 제품별(즉시 방출 단기 작용 오피오이드 및 지속 방출 장기 작용 오피오이드), 응용 분야(통증 관리, 마취, 설사 억제, 기침 억제, 중독 해소 및 기타), 투여 경로(경구, 주사 및 경피 패치), 유통 채널(병원 약국 및 소매 약국)

BMIRE00031031 | Pages: 74 | Pharmaceuticals | Nov 2024 | Type: Regional | Status: Published
남미 및 중미 오피오이드 시장은 2022년에 4억 7,828만 달러 규모였으며 2030년까지 5억 8,407만 달러에 도달할 것으로 예상되며 2022년에서 2030년까지 2.5%의 CAGR을 기록할 것으로 추산됩니다.

노인 인구 증가가 남미 및 중미 오피오이드 시장을 촉진합니다

대부분의 노인은 만성 통증을 겪으며 일상 생활을 수행할 힘이 감소합니다. 노인 인구는 뼈 및 관절 질환, 관절염, 암 및 통증을 유발하는 기타 만성 질환으로 널리 고통받습니다. 2018년 2월 세계보건기구(WHO) 데이터에 따르면 노인 인구는 2015년 12%에 비해 2050년까지 22% 증가할 것으로 추산됩니다. 또한 이 데이터는 저소득 및 중소득 국가가 이러한 급증의 거의 80%를 차지할 것이라고 밝혔습니다. 선진국 중 다수도 노인 인구가 크게 증가하고 있는데, 이는 개선된 의료 시설과 더 나은 의료 서비스에 의해 주도되고 있습니다. 이로 인해 이 지역의 기대 수명이 증가했습니다. 고령화 인구는 주로 통증 관리 솔루션에 대한 수요 증가를 통해 오피오이드 시장을 주도합니다. 또한 노인은 통증 관리가 필요한 수술과 의료 시술을 받는 경우가 많습니다. 따라서 이 지역 전체의 노인 인구 증가는 오피오이드 시장 성장을 주도합니다.

남미 및 중미 오피오이드 시장 개요

Pan American Health Organization(PAHO)의 데이터에 따르면 브라질에는 60세 이상의 노인이 3,000만 명이 넘으며, 이는 국가 인구의 13%를 차지합니다. 2030년까지 이 수는 약 5,000만 명에 도달하여 브라질 인구의 24%를 차지할 것으로 예상됩니다. 브라질 지리 및 통계 연구소에 따르면, 2050년까지 65세 이상의 인구가 브라질 전체 인구의 36%를 차지할 것으로 예상됩니다. 만성 통증은 노인에게 가장 흔한 질환 중 하나입니다. 이 질환을 앓고 있는 사람들은 오피오이드 제품을 선호하여 오피오이드 처방이 증가합니다.

브라질 보건 규제 기관(ANVISA)과 브라질 사립 병원 시스템에 따르면 브라질은 COVID-19 팬데믹의 발병으로 심각한 피해를 입었으며 2022년 4월 현재 70만 명이 사망했습니다. 브라질 보건 규제 기관(ANVISA)과 브라질 사립 병원 시스템에 따르면, 백신 공급이 지연되어 국민의 건강 상태가 악화되어 중증 환자의 입원 및 인공호흡이 증가하여 기관 삽관 시 진정제로 사용되는 펜타닐에 대한 수요가 급증했습니다.

또한 2023년 4월 The Lancet Regional Health-Americas에 발표된 데이터에 따르면, 브라질에서는 지난 20년 동안 의료 및 비의료적 목적을 포함하여 처방 오피오이드 사용이 증가했으며, 이것이 브라질 시장을 주도하고 있습니다.

남중미 오피오이드 시장 수익 및 2030년 예측(백만 달러)

남중미 오피오이드 시장 세분화

남중미 오피오이드 시장은 제품, 용도, 투여 경로, 유통 채널 및 국가로 분류됩니다.

제품을 기준으로 남중미 오피오이드 시장은 즉시 방출 단기 작용 오피오이드와 지연 방출 장기 작용 오피오이드로 세분화됩니다. 즉시 방출 단기 작용 오피오이드 세그먼트는 2022년에 더 큰 시장 점유율을 차지했습니다. 즉시 방출 단기 작용 오피오이드는 옥시코돈, 하이드로코돈, 트라마돌, 코딘, 프로폭시펜 등으로 세분화됩니다. 연장 방출 장기 작용 오피오이드는 옥시코돈, 펜타닐, 모르핀, 메타돈 등으로 세분화됩니다.

적용 측면에서 남미 및 중미 오피오이드 시장은 통증 관리, 마취, 설사 억제, 기침 억제, 중독 제거 등으로 분류됩니다. 통증 관리 세그먼트는 2022년에 가장 큰 시장 점유율을 차지했습니다.

투여 경로에 따라 남미 및 중미 오피오이드 시장은 경구, 주사 및 경피 패치로 세분화됩니다. 경구 세그먼트는 2022년에 가장 큰 시장 점유율을 차지했습니다.

유통 채널별로 남미 및 중미 오피오이드 시장은 병원 약국과 소매 약국으로 나뉩니다. 병원 약국 세그먼트는 2022년에 더 큰 시장 점유율을 차지했습니다.

국가별로 남미 및 중미 오피오이드 시장은 브라질, 아르헨티나 및 LATUM의 나머지 지역으로 세분화됩니다. 브라질은 2022년에 남미 및 중미 오피오이드 시장 점유율을 지배했습니다.

Endo International plc, Mallinckrodt Plc, Neuraxpharm Pharmaceuticals SL, Rusan Pharma Ltd, Teva Pharmaceutical Industries Ltd는 남미 및 중미 오피오이드 시장에서 운영되는 주요 회사 중 일부입니다.

TABLE OF CONTENTS

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. South & Central America Opioids Market - Key Market Dynamics

4.1 Market Drivers

4.1.1 Surging Chronic Pain Incidence

4.1.2 Increasing Geriatric Population

4.2 Market Restraints

4.2.1 Increasing Drug Abuse

4.3 Market Opportunities

4.3.1 Strategic Initiatives by Market Players

4.4 Impact of Drivers and Restraints:

5. Opioids Market - South & Central America Analysis

5.1 South & Central America Opioids Market Revenue (US$ Million), 2020-2030

5.2 South & Central America Opioids Market Forecast Analysis

6. South & Central America Opioids Market Analysis - by Product

6.1 Immediate Release Short Acting Opioid

6.1.1 Overview

6.1.2 Immediate Release Short Acting Opioid: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

6.1.2.1 South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid

6.2 Extended Release Long-Acting Opioid

6.2.1 Overview

6.2.2 Extended Release Long-Acting Opioid: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

6.2.2.1 South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid

7. South & Central America Opioids Market Analysis - by Application

7.1 Pain Management

7.1.1 Overview

7.1.2 Pain Management: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

7.2 Anesthesia

7.2.1 Overview

7.2.2 Anesthesia: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

7.3 Diarrhea Suppression

7.3.1 Overview

7.3.2 Diarrhea Suppression: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Cough Suppression

7.4.1 Overview

7.4.2 Cough Suppression: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

7.5 De-Addiction

7.5.1 Overview

7.5.2 De-Addiction: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

7.6 Others

7.6.1 Overview

7.6.2 Others: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Opioids Market Analysis - by Route of Administration

8.1 Oral

8.1.1 Overview

8.1.2 Oral: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

8.2 Injectable

8.2.1 Overview

8.2.2 Injectable: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

8.3 Transdermal Patch

8.3.1 Overview

8.3.2 Transdermal Patch: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Opioids Market Analysis - by Distribution Channel

9.1 Hospital Pharmacies

9.1.1 Overview

9.1.2 Hospital Pharmacies: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

9.2 Retail Pharmacies

9.2.1 Overview

9.2.2 Retail Pharmacies: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Opioids Market - Country Analysis

10.1 South & Central America

10.1.1 South & Central America Opioids Market, by Key Countries - Revenue (2022) (US$ Million)

10.1.2 South & Central America: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)

10.1.2.1 South & Central America: Opioids Market - Revenue and Forecast Analysis - by Country

10.1.2.2 Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

10.1.2.2.1 Brazil: South & Central America Opioids Market Breakdown, by Product

10.1.2.2.2 Brazil: South & Central America Opioids Market Breakdown, by Immediate Release Short Acting Opioid

10.1.2.2.3 Brazil: South & Central America Opioids Market Breakdown, by Extended Release Long Acting Opioid

10.1.2.2.4 Brazil: South & Central America Opioids Market Breakdown, by Application

10.1.2.2.5 Brazil: South & Central America Opioids Market Breakdown, by Route of Administration

10.1.2.2.6 Brazil: South & Central America Opioids Market Breakdown, by Distribution Channel

10.1.2.3 Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

10.1.2.3.1 Argentina: South & Central America Opioids Market Breakdown, by Product

10.1.2.3.2 Argentina: South & Central America Opioids Market Breakdown, by Immediate Release Short Acting Opioid

10.1.2.3.3 Argentina: South & Central America Opioids Market Breakdown, by Extended Release Long-Acting Opioid

10.1.2.3.4 Argentina: South & Central America Opioids Market Breakdown, by Application

10.1.2.3.5 Argentina: South & Central America Opioids Market Breakdown, by Route of Administration

10.1.2.3.6 Argentina: South & Central America Opioids Market Breakdown, by Distribution Channel

10.1.2.4 Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million)

10.1.2.4.1 Rest of South & Central America: Opioids Market Breakdown, by Product

10.1.2.4.2 Rest of South & Central America: Opioids Market Breakdown, by Immediate Release Short Acting Opioid

10.1.2.4.3 Rest of South & Central America: Opioids Market Breakdown, by Extended Release Long Acting Opioid

10.1.2.4.4 Rest of South & Central America: Opioids Market Breakdown, by Application

10.1.2.4.5 Rest of South & Central America: Opioids Market Breakdown, by Route of Administration

10.1.2.4.6 Rest of South & Central America: Opioids Market Breakdown, by Distribution Channel

11. Industry Landscape

11.1 Overview

11.2 Growth Strategies in Opioids Market

11.3 Organic Growth Strategies

11.3.1 Overview

11.4 Inorganic Growth Strategies

11.4.1 Overview

12. Company Profiles

12.1 Endo International plc

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Mallinckrodt Plc

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Neuraxpharm Pharmaceuticals SL

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Rusan Pharma Ltd

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Teva Pharmaceutical Industries Ltd

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

 

 

 

List of Tables

Table 1. South & Central America Opioids Market Segmentation

Table 2. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Table 3. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product

Table 4. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid

Table 5. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid

Table 6. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application

Table 7. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration

Table 8. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel

Table 9. South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Country

Table 10. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product

Table 11. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid

Table 12. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long Acting Opioid

Table 13. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application

Table 14. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration

Table 15. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel

Table 16. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product

Table 17. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid

Table 18. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid

Table 19. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application

Table 20. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration

Table 21. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel

Table 22. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product

Table 23. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid

Table 24. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long Acting Opioid

Table 25. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application

Table 26. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration

Table 27. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel

Table 28. Recent Organic Growth Strategies in Opioids Market

Table 29. Recent Inorganic Growth Strategies in the Opioids Market

Table 30. Glossary of Terms, Opioids Market

 

List of Figures

Figure 1. South & Central America Opioids Market Segmentation, by Country

Figure 2. South & Central America Opioids Market - Key Market Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. South & Central America Opioids Market Revenue (US$ Million), 2020-2030

Figure 5. South & Central America Opioids Market Share (%) - by Product (2022 and 2030)

Figure 6. Immediate Release Short Acting Opioid: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Extended Release Long-Acting Opioid: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. South & Central America Opioids Market Share (%) - by Application (2022 and 2030)

Figure 9. Pain Management: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 10. Anesthesia: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Diarrhea Suppression: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. Cough Suppression: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. De-Addiction: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Others: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. South & Central America Opioids Market Share (%) - by Route of Administration (2022 and 2030)

Figure 16. Oral: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Injectable: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Transdermal Patch: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. South & Central America Opioids Market Share (%) - by Distribution Channel (2022 and 2030)

Figure 20. Hospital Pharmacies: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 21. Retail Pharmacies: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 22. South & Central America: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)

Figure 23. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 24. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 25. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million)

Figure 26. Growth Strategies in Opioids Market

 

 

  1. Endo International plc
  2. Mallinckrodt Plc
  3. Neuraxpharm Pharmaceuticals SL
  4. Rusan Pharma Ltd
  5. Teva Pharmaceutical Industries Ltd
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America opioids market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the South & Central America opioids market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America opioids market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2840
Site License
$4550
$3640
Enterprise License
$5550
$4440